Ashburn, États-Unis
€10,000 - €60,000
12 years as CEO of a biotech company. Took it public on NASDAQ in 2014.
Broad pharmaceutical experience in drug delivery, technology development and commercialization. Clinical and regulatory as well as business development expertize.
Médecine et Pharma
Immobilier
Finance
AIN aide les investisseurs et les entrepreneurs à établir des relations durables et rentables en vue de créer de meilleures entreprises et un avenir plus prometteur.